nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Methylprednisolone—multiple sclerosis	0.0658	0.178	CiPCiCtD
Fluocinonide—Methylprednisolone—multiple sclerosis	0.0646	0.254	CrCtD
Fluocinonide—Betamethasone—multiple sclerosis	0.0636	0.25	CrCtD
Fluocinonide—Dexamethasone—multiple sclerosis	0.0636	0.25	CrCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Betamethasone—multiple sclerosis	0.0633	0.172	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Dexamethasone—multiple sclerosis	0.0633	0.172	CiPCiCtD
Fluocinonide—Triamcinolone—multiple sclerosis	0.0621	0.245	CrCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Triamcinolone—multiple sclerosis	0.0612	0.166	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisolone—multiple sclerosis	0.0593	0.161	CiPCiCtD
Fluocinonide—Corticosteroid Hormone Receptor Agonists—Prednisone—multiple sclerosis	0.056	0.152	CiPCiCtD
Fluocinonide—SERPINA6—Triamcinolone—multiple sclerosis	0.0329	0.231	CbGbCtD
Fluocinonide—SERPINA6—Prednisolone—multiple sclerosis	0.0279	0.195	CbGbCtD
Fluocinonide—NR3C1—Methylprednisolone—multiple sclerosis	0.0203	0.142	CbGbCtD
Fluocinonide—NR3C1—Triamcinolone—multiple sclerosis	0.0154	0.108	CbGbCtD
Fluocinonide—NR3C1—Betamethasone—multiple sclerosis	0.0132	0.0925	CbGbCtD
Fluocinonide—NR3C1—Prednisolone—multiple sclerosis	0.013	0.0913	CbGbCtD
Fluocinonide—NR3C1—Prednisone—multiple sclerosis	0.0123	0.0862	CbGbCtD
Fluocinonide—NR3C1—Dexamethasone—multiple sclerosis	0.00768	0.0538	CbGbCtD
Fluocinonide—Ciclesonide—Methylprednisolone—multiple sclerosis	0.00202	0.0105	CrCrCtD
Fluocinonide—Fluticasone furoate—Dexamethasone—multiple sclerosis	0.00191	0.0099	CrCrCtD
Fluocinonide—Fluticasone furoate—Betamethasone—multiple sclerosis	0.00191	0.0099	CrCrCtD
Fluocinonide—Fluticasone furoate—Triamcinolone—multiple sclerosis	0.00187	0.00968	CrCrCtD
Fluocinonide—Ciclesonide—Prednisone—multiple sclerosis	0.00184	0.00955	CrCrCtD
Fluocinonide—Flurandrenolide—Methylprednisolone—multiple sclerosis	0.00181	0.00935	CrCrCtD
Fluocinonide—Ciclesonide—Prednisolone—multiple sclerosis	0.0018	0.00932	CrCrCtD
Fluocinonide—Flurandrenolide—Betamethasone—multiple sclerosis	0.00178	0.00921	CrCrCtD
Fluocinonide—Flurandrenolide—Dexamethasone—multiple sclerosis	0.00178	0.00921	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Methylprednisolone—multiple sclerosis	0.00175	0.00904	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Betamethasone—multiple sclerosis	0.00172	0.0089	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Dexamethasone—multiple sclerosis	0.00172	0.0089	CrCrCtD
Fluocinonide—Fluticasone Propionate—Methylprednisolone—multiple sclerosis	0.00169	0.00875	CrCrCtD
Fluocinonide—Difluprednate—Methylprednisolone—multiple sclerosis	0.00169	0.00875	CrCrCtD
Fluocinonide—Halobetasol Propionate—Methylprednisolone—multiple sclerosis	0.00169	0.00875	CrCrCtD
Fluocinonide—Flumethasone Pivalate—Triamcinolone—multiple sclerosis	0.00168	0.0087	CrCrCtD
Fluocinonide—Halobetasol Propionate—Betamethasone—multiple sclerosis	0.00166	0.00861	CrCrCtD
Fluocinonide—Halobetasol Propionate—Dexamethasone—multiple sclerosis	0.00166	0.00861	CrCrCtD
Fluocinonide—Fluticasone Propionate—Dexamethasone—multiple sclerosis	0.00166	0.00861	CrCrCtD
Fluocinonide—Fluticasone Propionate—Betamethasone—multiple sclerosis	0.00166	0.00861	CrCrCtD
Fluocinonide—Difluprednate—Dexamethasone—multiple sclerosis	0.00166	0.00861	CrCrCtD
Fluocinonide—Difluprednate—Betamethasone—multiple sclerosis	0.00166	0.00861	CrCrCtD
Fluocinonide—Halobetasol Propionate—Triamcinolone—multiple sclerosis	0.00162	0.00842	CrCrCtD
Fluocinonide—Difluprednate—Triamcinolone—multiple sclerosis	0.00162	0.00842	CrCrCtD
Fluocinonide—Fluticasone Propionate—Triamcinolone—multiple sclerosis	0.00162	0.00842	CrCrCtD
Fluocinonide—Flurandrenolide—Prednisolone—multiple sclerosis	0.00161	0.00833	CrCrCtD
Fluocinonide—Clocortolone—Methylprednisolone—multiple sclerosis	0.00159	0.00823	CrCrCtD
Fluocinonide—Clocortolone—Betamethasone—multiple sclerosis	0.00156	0.0081	CrCrCtD
Fluocinonide—Clocortolone—Dexamethasone—multiple sclerosis	0.00156	0.0081	CrCrCtD
Fluocinonide—Beclomethasone—Betamethasone—multiple sclerosis	0.00156	0.0081	CrCrCtD
Fluocinonide—Beclomethasone—Dexamethasone—multiple sclerosis	0.00156	0.0081	CrCrCtD
Fluocinonide—Fluocortolone—Methylprednisolone—multiple sclerosis	0.00154	0.00799	CrCrCtD
Fluocinonide—Beclomethasone—Triamcinolone—multiple sclerosis	0.00153	0.00791	CrCrCtD
Fluocinonide—Clocortolone—Triamcinolone—multiple sclerosis	0.00153	0.00791	CrCrCtD
Fluocinonide—Fluocortolone—Betamethasone—multiple sclerosis	0.00152	0.00787	CrCrCtD
Fluocinonide—Fluocortolone—Dexamethasone—multiple sclerosis	0.00152	0.00787	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Methylprednisolone—multiple sclerosis	0.0015	0.00777	CrCrCtD
Fluocinonide—Fluocortolone—Triamcinolone—multiple sclerosis	0.00148	0.00769	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Betamethasone—multiple sclerosis	0.00148	0.00765	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Dexamethasone—multiple sclerosis	0.00148	0.00765	CrCrCtD
Fluocinonide—Budesonide—Methylprednisolone—multiple sclerosis	0.00146	0.00756	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Triamcinolone—multiple sclerosis	0.00144	0.00747	CrCrCtD
Fluocinonide—Budesonide—Dexamethasone—multiple sclerosis	0.00144	0.00744	CrCrCtD
Fluocinonide—Budesonide—Betamethasone—multiple sclerosis	0.00144	0.00744	CrCrCtD
Fluocinonide—Amcinonide—Dexamethasone—multiple sclerosis	0.00144	0.00744	CrCrCtD
Fluocinonide—Amcinonide—Betamethasone—multiple sclerosis	0.00144	0.00744	CrCrCtD
Fluocinonide—Diflorasone—Methylprednisolone—multiple sclerosis	0.00142	0.00737	CrCrCtD
Fluocinonide—Flunisolide—Methylprednisolone—multiple sclerosis	0.00142	0.00737	CrCrCtD
Fluocinonide—Clobetasol propionate—Methylprednisolone—multiple sclerosis	0.00142	0.00737	CrCrCtD
Fluocinonide—Desonide—Methylprednisolone—multiple sclerosis	0.00142	0.00737	CrCrCtD
Fluocinonide—Clocortolone—Prednisolone—multiple sclerosis	0.00142	0.00733	CrCrCtD
Fluocinonide—Beclomethasone—Prednisolone—multiple sclerosis	0.00142	0.00733	CrCrCtD
Fluocinonide—Fluocortolone—Prednisone—multiple sclerosis	0.00141	0.00729	CrCrCtD
Fluocinonide—Amcinonide—Triamcinolone—multiple sclerosis	0.0014	0.00727	CrCrCtD
Fluocinonide—Budesonide—Triamcinolone—multiple sclerosis	0.0014	0.00727	CrCrCtD
Fluocinonide—Flunisolide—Dexamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Diflorasone—Betamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Diflorasone—Dexamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Flunisolide—Betamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Desonide—Dexamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Clobetasol propionate—Dexamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Clobetasol propionate—Betamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Desonide—Betamethasone—multiple sclerosis	0.0014	0.00725	CrCrCtD
Fluocinonide—Paramethasone—Methylprednisolone—multiple sclerosis	0.00139	0.00718	CrCrCtD
Fluocinonide—Fluocortolone—Prednisolone—multiple sclerosis	0.00137	0.00712	CrCrCtD
Fluocinonide—Diflorasone—Triamcinolone—multiple sclerosis	0.00137	0.00709	CrCrCtD
Fluocinonide—Flunisolide—Triamcinolone—multiple sclerosis	0.00137	0.00709	CrCrCtD
Fluocinonide—Desonide—Triamcinolone—multiple sclerosis	0.00137	0.00709	CrCrCtD
Fluocinonide—Clobetasol propionate—Triamcinolone—multiple sclerosis	0.00137	0.00709	CrCrCtD
Fluocinonide—Paramethasone—Dexamethasone—multiple sclerosis	0.00137	0.00707	CrCrCtD
Fluocinonide—Paramethasone—Betamethasone—multiple sclerosis	0.00137	0.00707	CrCrCtD
Fluocinonide—Desoximetasone—Methylprednisolone—multiple sclerosis	0.00135	0.00701	CrCrCtD
Fluocinonide—Fluocinolone Acetonide—Prednisolone—multiple sclerosis	0.00134	0.00692	CrCrCtD
Fluocinonide—Paramethasone—Triamcinolone—multiple sclerosis	0.00133	0.00691	CrCrCtD
Fluocinonide—Amcinonide—Prednisone—multiple sclerosis	0.00133	0.0069	CrCrCtD
Fluocinonide—Budesonide—Prednisone—multiple sclerosis	0.00133	0.0069	CrCrCtD
Fluocinonide—Desoximetasone—Dexamethasone—multiple sclerosis	0.00133	0.0069	CrCrCtD
Fluocinonide—Desoximetasone—Betamethasone—multiple sclerosis	0.00133	0.0069	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Methylprednisolone—multiple sclerosis	0.00132	0.00684	CrCrCtD
Fluocinonide—Mometasone—Methylprednisolone—multiple sclerosis	0.00132	0.00684	CrCrCtD
Fluocinonide—Triamcinolone—Methylprednisolone—multiple sclerosis	0.00132	0.00684	CrCrCtD
Fluocinonide—Fluorometholone—Methylprednisolone—multiple sclerosis	0.00132	0.00684	CrCrCtD
Fluocinonide—Desoximetasone—Triamcinolone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Budesonide—Prednisolone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Amcinonide—Prednisolone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Betamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Dexamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Mometasone—Betamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Triamcinolone—Dexamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Triamcinolone—Betamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Fluorometholone—Betamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Fluorometholone—Dexamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Mometasone—Dexamethasone—multiple sclerosis	0.0013	0.00674	CrCrCtD
Fluocinonide—Diflorasone—Prednisone—multiple sclerosis	0.0013	0.00672	CrCrCtD
Fluocinonide—Desonide—Prednisone—multiple sclerosis	0.0013	0.00672	CrCrCtD
Fluocinonide—Flunisolide—Prednisone—multiple sclerosis	0.0013	0.00672	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisone—multiple sclerosis	0.0013	0.00672	CrCrCtD
Fluocinonide—Dexamethasone—Methylprednisolone—multiple sclerosis	0.00129	0.00669	CrCrCtD
Fluocinonide—Rimexolone—Methylprednisolone—multiple sclerosis	0.00129	0.00669	CrCrCtD
Fluocinonide—Betamethasone—Methylprednisolone—multiple sclerosis	0.00129	0.00669	CrCrCtD
Fluocinonide—Dexamethasone—Betamethasone—multiple sclerosis	0.00127	0.00658	CrCrCtD
Fluocinonide—Betamethasone—Dexamethasone—multiple sclerosis	0.00127	0.00658	CrCrCtD
Fluocinonide—Rimexolone—Dexamethasone—multiple sclerosis	0.00127	0.00658	CrCrCtD
Fluocinonide—Rimexolone—Betamethasone—multiple sclerosis	0.00127	0.00658	CrCrCtD
Fluocinonide—Fluorometholone—Triamcinolone—multiple sclerosis	0.00127	0.00658	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Triamcinolone—multiple sclerosis	0.00127	0.00658	CrCrCtD
Fluocinonide—Mometasone—Triamcinolone—multiple sclerosis	0.00127	0.00658	CrCrCtD
Fluocinonide—Flunisolide—Prednisolone—multiple sclerosis	0.00127	0.00656	CrCrCtD
Fluocinonide—Diflorasone—Prednisolone—multiple sclerosis	0.00127	0.00656	CrCrCtD
Fluocinonide—Desonide—Prednisolone—multiple sclerosis	0.00127	0.00656	CrCrCtD
Fluocinonide—Clobetasol propionate—Prednisolone—multiple sclerosis	0.00127	0.00656	CrCrCtD
Fluocinonide—Paramethasone—Prednisone—multiple sclerosis	0.00127	0.00656	CrCrCtD
Fluocinonide—Rimexolone—Triamcinolone—multiple sclerosis	0.00124	0.00643	CrCrCtD
Fluocinonide—Dexamethasone—Triamcinolone—multiple sclerosis	0.00124	0.00643	CrCrCtD
Fluocinonide—Betamethasone—Triamcinolone—multiple sclerosis	0.00124	0.00643	CrCrCtD
Fluocinonide—Paramethasone—Prednisolone—multiple sclerosis	0.00124	0.0064	CrCrCtD
Fluocinonide—Desoximetasone—Prednisone—multiple sclerosis	0.00124	0.0064	CrCrCtD
Fluocinonide—Methylprednisolone—Dexamethasone—multiple sclerosis	0.00122	0.00629	CrCrCtD
Fluocinonide—Methylprednisolone—Betamethasone—multiple sclerosis	0.00122	0.00629	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisone—multiple sclerosis	0.00121	0.00625	CrCrCtD
Fluocinonide—Triamcinolone—Prednisone—multiple sclerosis	0.00121	0.00625	CrCrCtD
Fluocinonide—Mometasone—Prednisone—multiple sclerosis	0.00121	0.00625	CrCrCtD
Fluocinonide—Fluorometholone—Prednisone—multiple sclerosis	0.00121	0.00625	CrCrCtD
Fluocinonide—Desoximetasone—Prednisolone—multiple sclerosis	0.00121	0.00624	CrCrCtD
Fluocinonide—Methylprednisolone—Triamcinolone—multiple sclerosis	0.00119	0.00615	CrCrCtD
Fluocinonide—Rimexolone—Prednisone—multiple sclerosis	0.00118	0.0061	CrCrCtD
Fluocinonide—Dexamethasone—Prednisone—multiple sclerosis	0.00118	0.0061	CrCrCtD
Fluocinonide—Betamethasone—Prednisone—multiple sclerosis	0.00118	0.0061	CrCrCtD
Fluocinonide—Fluprednidene Acetate—Prednisolone—multiple sclerosis	0.00118	0.0061	CrCrCtD
Fluocinonide—Fluorometholone—Prednisolone—multiple sclerosis	0.00118	0.0061	CrCrCtD
Fluocinonide—Triamcinolone—Prednisolone—multiple sclerosis	0.00118	0.0061	CrCrCtD
Fluocinonide—Mometasone—Prednisolone—multiple sclerosis	0.00118	0.0061	CrCrCtD
Fluocinonide—Betamethasone—Prednisolone—multiple sclerosis	0.00115	0.00596	CrCrCtD
Fluocinonide—Dexamethasone—Prednisolone—multiple sclerosis	0.00115	0.00596	CrCrCtD
Fluocinonide—Rimexolone—Prednisolone—multiple sclerosis	0.00115	0.00596	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisone—multiple sclerosis	0.00113	0.00584	CrCrCtD
Fluocinonide—Methylprednisolone—Prednisolone—multiple sclerosis	0.0011	0.0057	CrCrCtD
Fluocinonide—Secondary infection—Azathioprine—multiple sclerosis	0.000614	0.0186	CcSEcCtD
Fluocinonide—Secondary adrenocortical insufficiency—Prednisone—multiple sclerosis	0.000501	0.0152	CcSEcCtD
Fluocinonide—Dermatitis perioral—Triamcinolone—multiple sclerosis	0.000485	0.0147	CcSEcCtD
Fluocinonide—Cushing's syndrome—Triamcinolone—multiple sclerosis	0.000485	0.0147	CcSEcCtD
Fluocinonide—Dermatitis perioral—Methylprednisolone—multiple sclerosis	0.000484	0.0147	CcSEcCtD
Fluocinonide—Telangiectasia—Methylprednisolone—multiple sclerosis	0.000466	0.0142	CcSEcCtD
Fluocinonide—Cataract subcapsular—Prednisolone—multiple sclerosis	0.000459	0.0139	CcSEcCtD
Fluocinonide—Dermatitis perioral—Betamethasone—multiple sclerosis	0.00044	0.0134	CcSEcCtD
Fluocinonide—Dermatitis perioral—Dexamethasone—multiple sclerosis	0.00044	0.0134	CcSEcCtD
Fluocinonide—Cushing's syndrome—Dexamethasone—multiple sclerosis	0.00044	0.0134	CcSEcCtD
Fluocinonide—Cushing's syndrome—Betamethasone—multiple sclerosis	0.00044	0.0134	CcSEcCtD
Fluocinonide—Acneiform eruption—Triamcinolone—multiple sclerosis	0.000436	0.0132	CcSEcCtD
Fluocinonide—Acneiform eruption—Methylprednisolone—multiple sclerosis	0.000435	0.0132	CcSEcCtD
Fluocinonide—Telangiectasia—Dexamethasone—multiple sclerosis	0.000424	0.0129	CcSEcCtD
Fluocinonide—Telangiectasia—Betamethasone—multiple sclerosis	0.000424	0.0129	CcSEcCtD
Fluocinonide—Cataract subcapsular—Triamcinolone—multiple sclerosis	0.000422	0.0128	CcSEcCtD
Fluocinonide—Cataract subcapsular—Methylprednisolone—multiple sclerosis	0.000421	0.0128	CcSEcCtD
Fluocinonide—Acneiform eruption—Dexamethasone—multiple sclerosis	0.000395	0.012	CcSEcCtD
Fluocinonide—Acneiform eruption—Betamethasone—multiple sclerosis	0.000395	0.012	CcSEcCtD
Fluocinonide—SMO—medulla oblongata—multiple sclerosis	0.000384	0.104	CbGeAlD
Fluocinonide—Cushing's syndrome—Prednisone—multiple sclerosis	0.000383	0.0116	CcSEcCtD
Fluocinonide—Cataract subcapsular—Betamethasone—multiple sclerosis	0.000383	0.0116	CcSEcCtD
Fluocinonide—Cataract subcapsular—Dexamethasone—multiple sclerosis	0.000383	0.0116	CcSEcCtD
Fluocinonide—Skin striae—Prednisolone—multiple sclerosis	0.000376	0.0114	CcSEcCtD
Fluocinonide—Miliaria—Triamcinolone—multiple sclerosis	0.000375	0.0114	CcSEcCtD
Fluocinonide—Secondary infection—Triamcinolone—multiple sclerosis	0.000375	0.0114	CcSEcCtD
Fluocinonide—Secondary infection—Methylprednisolone—multiple sclerosis	0.000374	0.0113	CcSEcCtD
Fluocinonide—Miliaria—Methylprednisolone—multiple sclerosis	0.000374	0.0113	CcSEcCtD
Fluocinonide—Telangiectasia—Prednisone—multiple sclerosis	0.000369	0.0112	CcSEcCtD
Fluocinonide—Atrophy—Prednisolone—multiple sclerosis	0.000367	0.0112	CcSEcCtD
Fluocinonide—Skin atrophy—Triamcinolone—multiple sclerosis	0.000365	0.0111	CcSEcCtD
Fluocinonide—Skin atrophy—Methylprednisolone—multiple sclerosis	0.000364	0.011	CcSEcCtD
Fluocinonide—SMO—midbrain—multiple sclerosis	0.000351	0.0955	CbGeAlD
Fluocinonide—Skin striae—Triamcinolone—multiple sclerosis	0.000346	0.0105	CcSEcCtD
Fluocinonide—Skin striae—Methylprednisolone—multiple sclerosis	0.000345	0.0105	CcSEcCtD
Fluocinonide—Acneiform eruption—Prednisone—multiple sclerosis	0.000344	0.0105	CcSEcCtD
Fluocinonide—SMO—spinal cord—multiple sclerosis	0.000342	0.0932	CbGeAlD
Fluocinonide—Secondary infection—Betamethasone—multiple sclerosis	0.00034	0.0103	CcSEcCtD
Fluocinonide—Miliaria—Betamethasone—multiple sclerosis	0.00034	0.0103	CcSEcCtD
Fluocinonide—Miliaria—Dexamethasone—multiple sclerosis	0.00034	0.0103	CcSEcCtD
Fluocinonide—Secondary infection—Dexamethasone—multiple sclerosis	0.00034	0.0103	CcSEcCtD
Fluocinonide—Atrophy—Triamcinolone—multiple sclerosis	0.000338	0.0103	CcSEcCtD
Fluocinonide—Atrophy—Methylprednisolone—multiple sclerosis	0.000337	0.0102	CcSEcCtD
Fluocinonide—Cataract subcapsular—Prednisone—multiple sclerosis	0.000333	0.0101	CcSEcCtD
Fluocinonide—Skin atrophy—Betamethasone—multiple sclerosis	0.000331	0.01	CcSEcCtD
Fluocinonide—Skin atrophy—Dexamethasone—multiple sclerosis	0.000331	0.01	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Triamcinolone—multiple sclerosis	0.000322	0.00978	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Methylprednisolone—multiple sclerosis	0.000322	0.00976	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Triamcinolone—multiple sclerosis	0.000315	0.00956	CcSEcCtD
Fluocinonide—Skin striae—Dexamethasone—multiple sclerosis	0.000314	0.00954	CcSEcCtD
Fluocinonide—Skin striae—Betamethasone—multiple sclerosis	0.000314	0.00954	CcSEcCtD
Fluocinonide—NR3C1—nerve—multiple sclerosis	0.000309	0.0842	CbGeAlD
Fluocinonide—Telangiectasia—Methotrexate—multiple sclerosis	0.000309	0.00937	CcSEcCtD
Fluocinonide—Atrophy—Dexamethasone—multiple sclerosis	0.000306	0.0093	CcSEcCtD
Fluocinonide—Atrophy—Betamethasone—multiple sclerosis	0.000306	0.0093	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—S1PR1—multiple sclerosis	0.000295	0.0652	CbGpPWpGaD
Fluocinonide—Dermatitis acneiform—Dexamethasone—multiple sclerosis	0.000292	0.00888	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Betamethasone—multiple sclerosis	0.000292	0.00888	CcSEcCtD
Fluocinonide—Hypertrichosis—Triamcinolone—multiple sclerosis	0.00029	0.00879	CcSEcCtD
Fluocinonide—Hypertrichosis—Methylprednisolone—multiple sclerosis	0.000289	0.00877	CcSEcCtD
Fluocinonide—SMO—nervous system—multiple sclerosis	0.000288	0.0785	CbGeAlD
Fluocinonide—Skin atrophy—Prednisone—multiple sclerosis	0.000288	0.00874	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Dexamethasone—multiple sclerosis	0.000286	0.00868	CcSEcCtD
Fluocinonide—Allergic contact dermatitis—Betamethasone—multiple sclerosis	0.000286	0.00868	CcSEcCtD
Fluocinonide—Leukoderma—Prednisolone—multiple sclerosis	0.000282	0.00855	CcSEcCtD
Fluocinonide—SMO—central nervous system—multiple sclerosis	0.000278	0.0756	CbGeAlD
Fluocinonide—Skin striae—Prednisone—multiple sclerosis	0.000274	0.0083	CcSEcCtD
Fluocinonide—SMO—cerebellum—multiple sclerosis	0.000271	0.0739	CbGeAlD
Fluocinonide—Atrophy—Prednisone—multiple sclerosis	0.000267	0.0081	CcSEcCtD
Fluocinonide—Hypertrichosis—Betamethasone—multiple sclerosis	0.000263	0.00798	CcSEcCtD
Fluocinonide—Hypertrichosis—Dexamethasone—multiple sclerosis	0.000263	0.00798	CcSEcCtD
Fluocinonide—Leukoderma—Triamcinolone—multiple sclerosis	0.000259	0.00786	CcSEcCtD
Fluocinonide—Leukoderma—Methylprednisolone—multiple sclerosis	0.000258	0.00784	CcSEcCtD
Fluocinonide—Dermatitis acneiform—Prednisone—multiple sclerosis	0.000255	0.00773	CcSEcCtD
Fluocinonide—SMO—Signaling by Hedgehog—GPC5—multiple sclerosis	0.000242	0.0534	CbGpPWpGaD
Fluocinonide—Leukoderma—Betamethasone—multiple sclerosis	0.000235	0.00713	CcSEcCtD
Fluocinonide—Leukoderma—Dexamethasone—multiple sclerosis	0.000235	0.00713	CcSEcCtD
Fluocinonide—Application site reaction—Triamcinolone—multiple sclerosis	0.000235	0.00713	CcSEcCtD
Fluocinonide—Hypertrichosis—Prednisone—multiple sclerosis	0.000229	0.00695	CcSEcCtD
Fluocinonide—SMO—brain—multiple sclerosis	0.00022	0.06	CbGeAlD
Fluocinonide—Leukoderma—Prednisone—multiple sclerosis	0.000205	0.00621	CcSEcCtD
Fluocinonide—Swelling—Cladribine—multiple sclerosis	0.000183	0.00555	CcSEcCtD
Fluocinonide—Folliculitis—Triamcinolone—multiple sclerosis	0.000175	0.00532	CcSEcCtD
Fluocinonide—Folliculitis—Methylprednisolone—multiple sclerosis	0.000175	0.00531	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—HHEX—multiple sclerosis	0.000175	0.0385	CbGpPWpGaD
Fluocinonide—Leukoderma—Methotrexate—multiple sclerosis	0.000171	0.00519	CcSEcCtD
Fluocinonide—Folliculitis—Dexamethasone—multiple sclerosis	0.000159	0.00482	CcSEcCtD
Fluocinonide—Folliculitis—Betamethasone—multiple sclerosis	0.000159	0.00482	CcSEcCtD
Fluocinonide—SERPINA6—nervous system—multiple sclerosis	0.000159	0.0432	CbGeAlD
Fluocinonide—SERPINA6—central nervous system—multiple sclerosis	0.000153	0.0416	CbGeAlD
Fluocinonide—SERPINA6—cerebellum—multiple sclerosis	0.000149	0.0407	CbGeAlD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Fingolimod—multiple sclerosis	0.000145	0.00439	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—CXCR3—multiple sclerosis	0.000144	0.0319	CbGpPWpGaD
Fluocinonide—Infection—Fingolimod—multiple sclerosis	0.000139	0.00421	CcSEcCtD
Fluocinonide—Nervous system disorder—Fingolimod—multiple sclerosis	0.000137	0.00416	CcSEcCtD
Fluocinonide—Glycosuria—Triamcinolone—multiple sclerosis	0.000136	0.00413	CcSEcCtD
Fluocinonide—Skin disorder—Fingolimod—multiple sclerosis	0.000136	0.00412	CcSEcCtD
Fluocinonide—Glycosuria—Methylprednisolone—multiple sclerosis	0.000136	0.00412	CcSEcCtD
Fluocinonide—NR3C1—brainstem—multiple sclerosis	0.000133	0.0361	CbGeAlD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—RRM1—multiple sclerosis	0.000132	0.0291	CbGpPWpGaD
Fluocinonide—SMO—GPCRs, Other—CNR1—multiple sclerosis	0.00013	0.0286	CbGpPWpGaD
Fluocinonide—Glycosuria—Dexamethasone—multiple sclerosis	0.000123	0.00374	CcSEcCtD
Fluocinonide—Glycosuria—Betamethasone—multiple sclerosis	0.000123	0.00374	CcSEcCtD
Fluocinonide—SERPINA6—brain—multiple sclerosis	0.000121	0.033	CbGeAlD
Fluocinonide—Swelling—Mitoxantrone—multiple sclerosis	0.00012	0.00364	CcSEcCtD
Fluocinonide—Eruption—Methotrexate—multiple sclerosis	0.000118	0.00359	CcSEcCtD
Fluocinonide—Folliculitis—Methotrexate—multiple sclerosis	0.000116	0.00351	CcSEcCtD
Fluocinonide—Dermatitis contact—Triamcinolone—multiple sclerosis	0.000109	0.0033	CcSEcCtD
Fluocinonide—Glycosuria—Prednisone—multiple sclerosis	0.000107	0.00326	CcSEcCtD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—PLP1—multiple sclerosis	0.000106	0.0233	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Triamcinolone—multiple sclerosis	0.000105	0.00319	CcSEcCtD
Fluocinonide—Skin exfoliation—Methylprednisolone—multiple sclerosis	0.000105	0.00318	CcSEcCtD
Fluocinonide—Immune system disorder—Cladribine—multiple sclerosis	0.000101	0.00306	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—TBX21—multiple sclerosis	0.0001	0.0221	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—EOMES—multiple sclerosis	0.0001	0.0221	CbGpPWpGaD
Fluocinonide—Pruritus—Fingolimod—multiple sclerosis	9.88e-05	0.003	CcSEcCtD
Fluocinonide—Dermatitis contact—Betamethasone—multiple sclerosis	9.87e-05	0.003	CcSEcCtD
Fluocinonide—Dermatitis contact—Dexamethasone—multiple sclerosis	9.87e-05	0.003	CcSEcCtD
Fluocinonide—Erythema—Cladribine—multiple sclerosis	9.7e-05	0.00295	CcSEcCtD
Fluocinonide—Skin exfoliation—Dexamethasone—multiple sclerosis	9.54e-05	0.0029	CcSEcCtD
Fluocinonide—Skin exfoliation—Betamethasone—multiple sclerosis	9.54e-05	0.0029	CcSEcCtD
Fluocinonide—NR3C1—medulla oblongata—multiple sclerosis	9.26e-05	0.0252	CbGeAlD
Fluocinonide—Dizziness—Fingolimod—multiple sclerosis	9.24e-05	0.0028	CcSEcCtD
Fluocinonide—SMO—GPCRs, Other—CCR5—multiple sclerosis	9.05e-05	0.02	CbGpPWpGaD
Fluocinonide—Headache—Fingolimod—multiple sclerosis	8.75e-05	0.00266	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—TBX21—multiple sclerosis	8.63e-05	0.019	CbGpPWpGaD
Fluocinonide—NR3C1—midbrain—multiple sclerosis	8.46e-05	0.023	CbGeAlD
Fluocinonide—SMO—GPCR ligand binding—S1PR1—multiple sclerosis	8.37e-05	0.0185	CbGpPWpGaD
Fluocinonide—Skin exfoliation—Prednisone—multiple sclerosis	8.3e-05	0.00252	CcSEcCtD
Fluocinonide—Hyperglycaemia—Mitoxantrone—multiple sclerosis	8.26e-05	0.00251	CcSEcCtD
Fluocinonide—NR3C1—spinal cord—multiple sclerosis	8.26e-05	0.0225	CbGeAlD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	8.2e-05	0.00249	CcSEcCtD
Fluocinonide—Immune system disorder—Azathioprine—multiple sclerosis	8.19e-05	0.00249	CcSEcCtD
Fluocinonide—Dry skin—Prednisolone—multiple sclerosis	7.96e-05	0.00242	CcSEcCtD
Fluocinonide—Infection—Cladribine—multiple sclerosis	7.87e-05	0.00239	CcSEcCtD
Fluocinonide—Nervous system disorder—Cladribine—multiple sclerosis	7.77e-05	0.00236	CcSEcCtD
Fluocinonide—Skin disorder—Cladribine—multiple sclerosis	7.69e-05	0.00234	CcSEcCtD
Fluocinonide—Fluticasone Propionate—PGR—multiple sclerosis	7.64e-05	0.311	CrCbGaD
Fluocinonide—SMO—Hair Follicle Development: Induction (Part 1 of 3)—MYC—multiple sclerosis	7.59e-05	0.0167	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptors—PGR—multiple sclerosis	7.48e-05	0.0165	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNFRSF1A—multiple sclerosis	7.21e-05	0.0159	CbGpPWpGaD
Fluocinonide—Betamethasone—PGR—multiple sclerosis	7e-05	0.285	CrCbGaD
Fluocinonide—NR3C1—nervous system—multiple sclerosis	6.96e-05	0.0189	CbGeAlD
Fluocinonide—Skin exfoliation—Methotrexate—multiple sclerosis	6.94e-05	0.00211	CcSEcCtD
Fluocinonide—Pain—Cladribine—multiple sclerosis	6.77e-05	0.00206	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—GPR65—multiple sclerosis	6.75e-05	0.0149	CbGpPWpGaD
Fluocinonide—NR3C1—central nervous system—multiple sclerosis	6.7e-05	0.0182	CbGeAlD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	6.67e-05	0.00203	CcSEcCtD
Fluocinonide—Dry skin—Betamethasone—multiple sclerosis	6.65e-05	0.00202	CcSEcCtD
Fluocinonide—Dry skin—Dexamethasone—multiple sclerosis	6.65e-05	0.00202	CcSEcCtD
Fluocinonide—NR3C1—Endoderm Differentiation—PABPC1—multiple sclerosis	6.61e-05	0.0146	CbGpPWpGaD
Fluocinonide—NR3C1—cerebellum—multiple sclerosis	6.55e-05	0.0178	CbGeAlD
Fluocinonide—Infection—Azathioprine—multiple sclerosis	6.4e-05	0.00194	CcSEcCtD
Fluocinonide—Erythema—Mitoxantrone—multiple sclerosis	6.38e-05	0.00194	CcSEcCtD
Fluocinonide—Skin disorder—Azathioprine—multiple sclerosis	6.25e-05	0.0019	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCR1—multiple sclerosis	6.17e-05	0.0136	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL13—multiple sclerosis	6.17e-05	0.0136	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—PGR—multiple sclerosis	5.91e-05	0.013	CbGpPWpGaD
Fluocinonide—Triamcinolone—BCHE—multiple sclerosis	5.85e-05	0.238	CrCbGaD
Fluocinonide—Hypersensitivity—Cladribine—multiple sclerosis	5.83e-05	0.00177	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—BDNF—multiple sclerosis	5.79e-05	0.0128	CbGpPWpGaD
Fluocinonide—Dry skin—Prednisone—multiple sclerosis	5.79e-05	0.00176	CcSEcCtD
Fluocinonide—Hyperglycaemia—Betamethasone—multiple sclerosis	5.65e-05	0.00172	CcSEcCtD
Fluocinonide—Hyperglycaemia—Dexamethasone—multiple sclerosis	5.65e-05	0.00172	CcSEcCtD
Fluocinonide—Pruritus—Cladribine—multiple sclerosis	5.6e-05	0.0017	CcSEcCtD
Fluocinonide—NR3C1—brain—multiple sclerosis	5.32e-05	0.0145	CbGeAlD
Fluocinonide—Dizziness—Cladribine—multiple sclerosis	5.24e-05	0.00159	CcSEcCtD
Fluocinonide—Erythema—Prednisolone—multiple sclerosis	5.23e-05	0.00159	CcSEcCtD
Fluocinonide—NR3C1—Nuclear Receptors—VDR—multiple sclerosis	5.22e-05	0.0115	CbGpPWpGaD
Fluocinonide—Infection—Mitoxantrone—multiple sclerosis	5.17e-05	0.00157	CcSEcCtD
Fluocinonide—Skin disorder—Mitoxantrone—multiple sclerosis	5.06e-05	0.00154	CcSEcCtD
Fluocinonide—Rash—Cladribine—multiple sclerosis	4.99e-05	0.00152	CcSEcCtD
Fluocinonide—Dermatitis—Cladribine—multiple sclerosis	4.99e-05	0.00151	CcSEcCtD
Fluocinonide—Immune system disorder—Methylprednisolone—multiple sclerosis	4.98e-05	0.00151	CcSEcCtD
Fluocinonide—Headache—Cladribine—multiple sclerosis	4.96e-05	0.00151	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—SELE—multiple sclerosis	4.96e-05	0.0109	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—FAS—multiple sclerosis	4.95e-05	0.0109	CbGpPWpGaD
Fluocinonide—Hyperglycaemia—Prednisone—multiple sclerosis	4.92e-05	0.00149	CcSEcCtD
Fluocinonide—Erythema—Triamcinolone—multiple sclerosis	4.81e-05	0.00146	CcSEcCtD
Fluocinonide—Erythema—Methylprednisolone—multiple sclerosis	4.8e-05	0.00146	CcSEcCtD
Fluocinonide—Hypersensitivity—Azathioprine—multiple sclerosis	4.74e-05	0.00144	CcSEcCtD
Fluocinonide—Pain—Mitoxantrone—multiple sclerosis	4.45e-05	0.00135	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCL3—multiple sclerosis	4.4e-05	0.00971	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—C4A—multiple sclerosis	4.39e-05	0.00968	CbGpPWpGaD
Fluocinonide—Erythema—Dexamethasone—multiple sclerosis	4.37e-05	0.00133	CcSEcCtD
Fluocinonide—Erythema—Betamethasone—multiple sclerosis	4.37e-05	0.00133	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—S1PR1—multiple sclerosis	4.3e-05	0.00949	CbGpPWpGaD
Fluocinonide—Dizziness—Azathioprine—multiple sclerosis	4.26e-05	0.00129	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—PTGER4—multiple sclerosis	4.23e-05	0.00935	CbGpPWpGaD
Fluocinonide—NR3C1—Nuclear Receptor transcription pathway—VDR—multiple sclerosis	4.13e-05	0.00911	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCR3—multiple sclerosis	4.09e-05	0.00903	CbGpPWpGaD
Fluocinonide—Dexamethasone—PGR—multiple sclerosis	4.07e-05	0.166	CrCbGaD
Fluocinonide—Rash—Azathioprine—multiple sclerosis	4.06e-05	0.00123	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	4.06e-05	0.00123	CcSEcCtD
Fluocinonide—Dermatitis—Azathioprine—multiple sclerosis	4.06e-05	0.00123	CcSEcCtD
Fluocinonide—Headache—Azathioprine—multiple sclerosis	4.03e-05	0.00122	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCR2—multiple sclerosis	3.98e-05	0.00878	CbGpPWpGaD
Fluocinonide—Immune system disorder—Prednisone—multiple sclerosis	3.95e-05	0.0012	CcSEcCtD
Fluocinonide—Infection—Triamcinolone—multiple sclerosis	3.9e-05	0.00118	CcSEcCtD
Fluocinonide—Infection—Methylprednisolone—multiple sclerosis	3.89e-05	0.00118	CcSEcCtD
Fluocinonide—Nervous system disorder—Methylprednisolone—multiple sclerosis	3.84e-05	0.00117	CcSEcCtD
Fluocinonide—Hypersensitivity—Mitoxantrone—multiple sclerosis	3.84e-05	0.00116	CcSEcCtD
Fluocinonide—Skin disorder—Methylprednisolone—multiple sclerosis	3.81e-05	0.00116	CcSEcCtD
Fluocinonide—Erythema—Prednisone—multiple sclerosis	3.8e-05	0.00115	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CNR1—multiple sclerosis	3.67e-05	0.00811	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—RGS1—multiple sclerosis	3.65e-05	0.00807	CbGpPWpGaD
Fluocinonide—Pain—Prednisolone—multiple sclerosis	3.65e-05	0.00111	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IFNB1—multiple sclerosis	3.59e-05	0.00793	CbGpPWpGaD
Fluocinonide—Infection—Betamethasone—multiple sclerosis	3.54e-05	0.00107	CcSEcCtD
Fluocinonide—Infection—Dexamethasone—multiple sclerosis	3.54e-05	0.00107	CcSEcCtD
Fluocinonide—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—MAPK1—multiple sclerosis	3.54e-05	0.00781	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Betamethasone—multiple sclerosis	3.49e-05	0.00106	CcSEcCtD
Fluocinonide—Nervous system disorder—Dexamethasone—multiple sclerosis	3.49e-05	0.00106	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—GPR65—multiple sclerosis	3.46e-05	0.00765	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—ZNF746—multiple sclerosis	3.38e-05	0.00747	CbGpPWpGaD
Fluocinonide—Pain—Triamcinolone—multiple sclerosis	3.36e-05	0.00102	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—LINGO1—multiple sclerosis	3.35e-05	0.0074	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—AQP4—multiple sclerosis	3.32e-05	0.00734	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CXCL10—multiple sclerosis	3.31e-05	0.0073	CbGpPWpGaD
Fluocinonide—Immune system disorder—Methotrexate—multiple sclerosis	3.3e-05	0.001	CcSEcCtD
Fluocinonide—Rash—Mitoxantrone—multiple sclerosis	3.28e-05	0.000996	CcSEcCtD
Fluocinonide—Dermatitis—Mitoxantrone—multiple sclerosis	3.28e-05	0.000996	CcSEcCtD
Fluocinonide—Headache—Mitoxantrone—multiple sclerosis	3.26e-05	0.00099	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	3.21e-05	0.000976	CcSEcCtD
Fluocinonide—Erythema—Methotrexate—multiple sclerosis	3.18e-05	0.000965	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CCR1—multiple sclerosis	3.17e-05	0.00699	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL13—multiple sclerosis	3.17e-05	0.00699	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Prednisolone—multiple sclerosis	3.15e-05	0.000955	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL10—multiple sclerosis	3.12e-05	0.00688	CbGpPWpGaD
Fluocinonide—Infection—Prednisone—multiple sclerosis	3.08e-05	0.000936	CcSEcCtD
Fluocinonide—Pain—Dexamethasone—multiple sclerosis	3.05e-05	0.000925	CcSEcCtD
Fluocinonide—Pain—Betamethasone—multiple sclerosis	3.05e-05	0.000925	CcSEcCtD
Fluocinonide—Nervous system disorder—Prednisone—multiple sclerosis	3.04e-05	0.000924	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL4—multiple sclerosis	3.03e-05	0.00669	CbGpPWpGaD
Fluocinonide—Skin disorder—Prednisone—multiple sclerosis	3.01e-05	0.000915	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—TNF—multiple sclerosis	2.99e-05	0.00661	CbGpPWpGaD
Fluocinonide—NR3C1—FOXA2 and FOXA3 transcription factor networks—ALB—multiple sclerosis	2.91e-05	0.00643	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TAGAP—multiple sclerosis	2.9e-05	0.00641	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Triamcinolone—multiple sclerosis	2.89e-05	0.000878	CcSEcCtD
Fluocinonide—Hypersensitivity—Methylprednisolone—multiple sclerosis	2.89e-05	0.000877	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—multiple sclerosis	2.85e-05	0.00629	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL5—multiple sclerosis	2.85e-05	0.00628	CbGpPWpGaD
Fluocinonide—Dizziness—Prednisolone—multiple sclerosis	2.82e-05	0.000857	CcSEcCtD
Fluocinonide—Pruritus—Triamcinolone—multiple sclerosis	2.78e-05	0.000844	CcSEcCtD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—multiple sclerosis	2.77e-05	0.00612	CbGpPWpGaD
Fluocinonide—Pruritus—Methylprednisolone—multiple sclerosis	2.77e-05	0.000842	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—HLA-A—multiple sclerosis	2.75e-05	0.00606	CbGpPWpGaD
Fluocinonide—Rash—Prednisolone—multiple sclerosis	2.69e-05	0.000817	CcSEcCtD
Fluocinonide—Dermatitis—Prednisolone—multiple sclerosis	2.69e-05	0.000817	CcSEcCtD
Fluocinonide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	2.69e-05	0.000816	CcSEcCtD
Fluocinonide—Headache—Prednisolone—multiple sclerosis	2.68e-05	0.000812	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL4—multiple sclerosis	2.67e-05	0.0059	CbGpPWpGaD
Fluocinonide—Dizziness—Triamcinolone—multiple sclerosis	2.6e-05	0.000788	CcSEcCtD
Fluocinonide—Dizziness—Methylprednisolone—multiple sclerosis	2.59e-05	0.000787	CcSEcCtD
Fluocinonide—Infection—Methotrexate—multiple sclerosis	2.58e-05	0.000782	CcSEcCtD
Fluocinonide—SMO—GPCR ligand binding—CCR5—multiple sclerosis	2.56e-05	0.00566	CbGpPWpGaD
Fluocinonide—Nervous system disorder—Methotrexate—multiple sclerosis	2.54e-05	0.000772	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—S1PR1—multiple sclerosis	2.54e-05	0.0056	CbGpPWpGaD
Fluocinonide—Pruritus—Dexamethasone—multiple sclerosis	2.52e-05	0.000765	CcSEcCtD
Fluocinonide—Pruritus—Betamethasone—multiple sclerosis	2.52e-05	0.000765	CcSEcCtD
Fluocinonide—Skin disorder—Methotrexate—multiple sclerosis	2.52e-05	0.000765	CcSEcCtD
Fluocinonide—Rash—Triamcinolone—multiple sclerosis	2.48e-05	0.000752	CcSEcCtD
Fluocinonide—Dermatitis—Triamcinolone—multiple sclerosis	2.47e-05	0.000751	CcSEcCtD
Fluocinonide—Rash—Methylprednisolone—multiple sclerosis	2.47e-05	0.00075	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—GPC5—multiple sclerosis	2.47e-05	0.00545	CbGpPWpGaD
Fluocinonide—Dermatitis—Methylprednisolone—multiple sclerosis	2.47e-05	0.000749	CcSEcCtD
Fluocinonide—Headache—Triamcinolone—multiple sclerosis	2.46e-05	0.000747	CcSEcCtD
Fluocinonide—Headache—Methylprednisolone—multiple sclerosis	2.45e-05	0.000745	CcSEcCtD
Fluocinonide—NR3C1—Transcription factor regulation in adipogenesis—IL6—multiple sclerosis	2.42e-05	0.00533	CbGpPWpGaD
Fluocinonide—Dizziness—Betamethasone—multiple sclerosis	2.36e-05	0.000715	CcSEcCtD
Fluocinonide—Dizziness—Dexamethasone—multiple sclerosis	2.36e-05	0.000715	CcSEcCtD
Fluocinonide—Hypersensitivity—Prednisone—multiple sclerosis	2.29e-05	0.000694	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MYC—multiple sclerosis	2.26e-05	0.00498	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL3—multiple sclerosis	2.26e-05	0.00498	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TGFB1—multiple sclerosis	2.25e-05	0.00497	CbGpPWpGaD
Fluocinonide—Rash—Betamethasone—multiple sclerosis	2.25e-05	0.000682	CcSEcCtD
Fluocinonide—Rash—Dexamethasone—multiple sclerosis	2.25e-05	0.000682	CcSEcCtD
Fluocinonide—Dermatitis—Betamethasone—multiple sclerosis	2.24e-05	0.000682	CcSEcCtD
Fluocinonide—Dermatitis—Dexamethasone—multiple sclerosis	2.24e-05	0.000682	CcSEcCtD
Fluocinonide—Headache—Betamethasone—multiple sclerosis	2.23e-05	0.000678	CcSEcCtD
Fluocinonide—Headache—Dexamethasone—multiple sclerosis	2.23e-05	0.000678	CcSEcCtD
Fluocinonide—Pain—Methotrexate—multiple sclerosis	2.22e-05	0.000673	CcSEcCtD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—MAPK1—multiple sclerosis	2.21e-05	0.00488	CbGpPWpGaD
Fluocinonide—Pruritus—Prednisone—multiple sclerosis	2.2e-05	0.000667	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—PTGER4—multiple sclerosis	2.17e-05	0.0048	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—RGS1—multiple sclerosis	2.16e-05	0.00477	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—CCL2—multiple sclerosis	2.16e-05	0.00476	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—ICAM1—multiple sclerosis	2.12e-05	0.00469	CbGpPWpGaD
Fluocinonide—SMO—Integrated Pancreatic Cancer Pathway—TNF—multiple sclerosis	2.1e-05	0.00464	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCR3—multiple sclerosis	2.1e-05	0.00463	CbGpPWpGaD
Fluocinonide—Dizziness—Prednisone—multiple sclerosis	2.05e-05	0.000623	CcSEcCtD
Fluocinonide—SMO—Signaling Pathways—GPR65—multiple sclerosis	2.05e-05	0.00452	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR2—multiple sclerosis	2.04e-05	0.00451	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—POMC—multiple sclerosis	2e-05	0.00442	CbGpPWpGaD
Fluocinonide—SMO—GPCR ligand binding—CCL2—multiple sclerosis	1.96e-05	0.00433	CbGpPWpGaD
Fluocinonide—Rash—Prednisone—multiple sclerosis	1.96e-05	0.000594	CcSEcCtD
Fluocinonide—Dermatitis—Prednisone—multiple sclerosis	1.95e-05	0.000594	CcSEcCtD
Fluocinonide—Headache—Prednisone—multiple sclerosis	1.94e-05	0.00059	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—POMC—multiple sclerosis	1.94e-05	0.00429	CbGpPWpGaD
Fluocinonide—Hypersensitivity—Methotrexate—multiple sclerosis	1.91e-05	0.00058	CcSEcCtD
Fluocinonide—SMO—Signaling by GPCR—CNR1—multiple sclerosis	1.88e-05	0.00416	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL13—multiple sclerosis	1.87e-05	0.00413	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR1—multiple sclerosis	1.87e-05	0.00413	CbGpPWpGaD
Fluocinonide—Pruritus—Methotrexate—multiple sclerosis	1.83e-05	0.000557	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IFNG—multiple sclerosis	1.83e-05	0.00405	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—BDNF—multiple sclerosis	1.72e-05	0.0038	CbGpPWpGaD
Fluocinonide—Dizziness—Methotrexate—multiple sclerosis	1.72e-05	0.000521	CcSEcCtD
Fluocinonide—NR3C1—Adipogenesis—FAS—multiple sclerosis	1.7e-05	0.00376	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CXCL10—multiple sclerosis	1.7e-05	0.00375	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL10—multiple sclerosis	1.64e-05	0.00362	CbGpPWpGaD
Fluocinonide—Rash—Methotrexate—multiple sclerosis	1.64e-05	0.000496	CcSEcCtD
Fluocinonide—Dermatitis—Methotrexate—multiple sclerosis	1.63e-05	0.000496	CcSEcCtD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL2—multiple sclerosis	1.63e-05	0.0036	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ZNF746—multiple sclerosis	1.63e-05	0.00359	CbGpPWpGaD
Fluocinonide—Headache—Methotrexate—multiple sclerosis	1.62e-05	0.000493	CcSEcCtD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IFNG—multiple sclerosis	1.62e-05	0.00357	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MMP9—multiple sclerosis	1.54e-05	0.0034	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PTBP1—multiple sclerosis	1.49e-05	0.00329	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL5—multiple sclerosis	1.46e-05	0.00322	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL2—multiple sclerosis	1.44e-05	0.00317	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL3—multiple sclerosis	1.33e-05	0.00294	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCR5—multiple sclerosis	1.32e-05	0.0029	CbGpPWpGaD
Fluocinonide—NR3C1—Endoderm Differentiation—TGFB1—multiple sclerosis	1.3e-05	0.00287	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL2RA—multiple sclerosis	1.3e-05	0.00286	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PTGER4—multiple sclerosis	1.28e-05	0.00283	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—MYC—multiple sclerosis	1.27e-05	0.00281	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—TGFB1—multiple sclerosis	1.27e-05	0.0028	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—PGR—multiple sclerosis	1.26e-05	0.00279	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCR3—multiple sclerosis	1.24e-05	0.00274	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CD28—multiple sclerosis	1.23e-05	0.00271	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR2—multiple sclerosis	1.21e-05	0.00266	CbGpPWpGaD
Fluocinonide—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—multiple sclerosis	1.13e-05	0.0025	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—U2AF2—multiple sclerosis	1.13e-05	0.00249	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—HNRNPA1—multiple sclerosis	1.13e-05	0.00249	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CNR1—multiple sclerosis	1.11e-05	0.00246	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—multiple sclerosis	1.1e-05	0.00242	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—POMC—multiple sclerosis	1.03e-05	0.00227	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—PGR—multiple sclerosis	1.02e-05	0.00225	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—CCL2—multiple sclerosis	1.01e-05	0.00222	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CXCL10—multiple sclerosis	1e-05	0.00221	CbGpPWpGaD
Fluocinonide—NR3C1—AP-1 transcription factor network—IL6—multiple sclerosis	9.57e-06	0.00211	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—TYK2—multiple sclerosis	9.14e-06	0.00202	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—ZFP36L1—multiple sclerosis	8.92e-06	0.00197	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CD86—multiple sclerosis	8.76e-06	0.00193	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL5—multiple sclerosis	8.63e-06	0.0019	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL1B—multiple sclerosis	8.61e-06	0.0019	CbGpPWpGaD
Fluocinonide—NR3C1—Glucocorticoid receptor regulatory network—IL6—multiple sclerosis	8.44e-06	0.00186	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—STAT3—multiple sclerosis	8.35e-06	0.00184	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—SPP1—multiple sclerosis	7.99e-06	0.00176	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCR5—multiple sclerosis	7.77e-06	0.00172	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TGFB1—multiple sclerosis	7.74e-06	0.00171	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2RA—multiple sclerosis	7.66e-06	0.00169	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL2—multiple sclerosis	7.6e-06	0.00168	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—TNF—multiple sclerosis	7.23e-06	0.0016	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—VDR—multiple sclerosis	7.13e-06	0.00157	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—APOE—multiple sclerosis	7.07e-06	0.00156	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PABPC1—multiple sclerosis	6.92e-06	0.00153	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CD80—multiple sclerosis	6.39e-06	0.00141	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—TNF—multiple sclerosis	6.25e-06	0.00138	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—RPL5—multiple sclerosis	6.24e-06	0.00138	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—POMC—multiple sclerosis	6.07e-06	0.00134	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—CCL2—multiple sclerosis	5.94e-06	0.00131	CbGpPWpGaD
Fluocinonide—NR3C1—Adipogenesis—IL6—multiple sclerosis	5.83e-06	0.00129	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—MAPK1—multiple sclerosis	5.82e-06	0.00128	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TYK2—multiple sclerosis	5.4e-06	0.00119	CbGpPWpGaD
Fluocinonide—NR3C1—SIDS Susceptibility Pathways—IL6—multiple sclerosis	5.04e-06	0.00111	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—PGR—multiple sclerosis	4.91e-06	0.00108	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL2—multiple sclerosis	4.49e-06	0.000991	CbGpPWpGaD
Fluocinonide—SMO—Signaling by GPCR—IL6—multiple sclerosis	4.47e-06	0.000986	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MMP9—multiple sclerosis	4.25e-06	0.000938	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—STAT3—multiple sclerosis	3.78e-06	0.000834	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MYC—multiple sclerosis	3.51e-06	0.000775	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—TGFB1—multiple sclerosis	3.5e-06	0.000773	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—MAPK1—multiple sclerosis	3.44e-06	0.000758	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—VDR—multiple sclerosis	3.43e-06	0.000758	CbGpPWpGaD
Fluocinonide—NR3C1—Generic Transcription Pathway—MYC—multiple sclerosis	2.83e-06	0.000626	CbGpPWpGaD
Fluocinonide—SMO—Signaling Pathways—IL6—multiple sclerosis	2.64e-06	0.000583	CbGpPWpGaD
Fluocinonide—NR3C1—Gene Expression—MYC—multiple sclerosis	1.36e-06	0.000301	CbGpPWpGaD
